-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Pbk6gKkCm3c2ul29Xb8d5gKPv8R8UuG2XPYQgBNuVd67MU2y8pvqX6FdZGDHWZyP yqtQk7Yfs7DIqJbgZLrJ9A== 0001144204-08-064368.txt : 20081114 0001144204-08-064368.hdr.sgml : 20081114 20081114160452 ACCESSION NUMBER: 0001144204-08-064368 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080930 FILED AS OF DATE: 20081114 DATE AS OF CHANGE: 20081114 EFFECTIVENESS DATE: 20081114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BAKER BROS ADVISORS LLC CENTRAL INDEX KEY: 0001263508 IRS NUMBER: 134093645 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-10519 FILM NUMBER: 081191308 BUSINESS ADDRESS: STREET 1: 667 MADISON AVENUE STREET 2: 17TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10021 BUSINESS PHONE: 2125212418 13F-HR 1 v131491_13fhr.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 13F FORM 13F COVER PAGE Report for the Calendar Year or Quarter Ended: September 30, 2008 Check here if Amendment [ ]; Amendment Number: _____ This Amendment (Check only one.): [ ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Baker Bros. Advisors, LLC -------------------------------------------- Address: 667 Madison Avenue, 21st Floor -------------------------------------------- New York, NY 10065-8029 -------------------------------------------- Form 13F File Number: 28-10519 The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Leo Kirby -------------------------------------------- Title: Chief Financial Officer -------------------------------------------- Phone: 212-339-5633 -------------------------------------------- Signature, Place, and Date of Signing: /s/ Leo Kirby New York, N.Y. November 12, 2008 - -------------------------- --------------------------- ---------------------- [Signature] [City, State] [Date] Report Type (Check only one.): [X] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) [_] 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) [_] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) List of Other Managers Reporting for this Manager: None FORM 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 0 ----------- Form 13F Information Table Entry Total: 90 ----------- Form 13F Information Table Entry Value: 1,313,500 ----------- (thousands) List of Other Included Managers: None Baker Brothers Form 13F 9-30-2008
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8 VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY Name of Issuer CUSIP (x1000) PRN AMT PRN CALL DISCRETION MANAGERS SOLE SHARED NONE - ---------------------------- ------- ------- ------- --- ---- ---------- -------- ---- ------ ---- Acadia Pharmaceuticals Inc. COM 004225108 7,616 2,841,751 SH SOLE 2,841,751 Acorda Therapeutics COM 00484M106 31,053 1,302,013 SH SOLE 1,302,013 Adolor Corp. COM 00724X102 878 254,515 SH SOLE 254,515 Allergan COM 018490102 1,859 36,100 SH SOLE 36,100 Allos Therapeutics Inc. COM 019777101 83,352 11,248,621 SH SOLE 11,248,621 Alsius Corp. COM 021211107 55 64,850 SH SOLE 64,850 Altus Pharmaceuticals Inc. COM 02216N105 72 65,477 SH SOLE 65,477 Amicus Therapeutics COM 03152W109 20,901 1,382,322 SH SOLE 1,382,322 Anadys Pharmaceuticals Inc. COM 03252Q408 1,200 452,835 SH SOLE 452,835 Anesiva Inc. COM 21872P501 551 377,441 SH SOLE 377,441 AP Pharma COM 00202J203 1,857 2,476,546 SH SOLE 2,476,546 Aradigm Corp. COM 038505301 39 100,000 SH SOLE 100,000 Ardea Biosciences Inc. COM 03969P107 60,573 4,379,803 SH SOLE 4,379,803 Arena Pharmaceuticals Inc. COM 040047102 136 27,246 SH SOLE 27,246 Array Biopharma Inc. COM 04269X105 808 105,169 SH SOLE 105,169 Autoimmune Inc. COM 052776101 34 26,100 SH SOLE 26,100 Auxilium COM 05334D107 110,811 3,420,103 SH SOLE 3,420,103 Biocryst Pharmaceuticals Inc. COM 09058V103 18,643 5,918,411 SH SOLE 5,918,411 Biomarin Pharmaceutical Inc. COM 09061G101 27,918 1,053,905 SH SOLE 1,053,905 Cadence Pharmaceuticals COM 12738T100 1,472 165,784 SH SOLE 165,784 Celgene COM 151020104 49,932 789,062 SH SOLE 789,062 Chelsea Therapeutics COM 163428105 3,693 1,136,263 SH SOLE 1,136,263 Critical Therapeutics Inc. COM 22674T105 214 1,124,474 SH SOLE 1,124,474 Cubist COM 229678AC1 4,208 189,293 SH SOLE 189,293 Curagen COM 23126R101 311 388,613 SH SOLE 388,613 Cyclacel Pharmaceuticals COM 23254L108 229 191,186 SH SOLE 191,186 Cyclacel Pharmaceuticals Pfd. Conv. Ex 6% PFD CONV EX 23254L207 196 95,500 SH SOLE 95,500 Cytokinetics Inc. COM 23282W100 6,718 1,417,212 SH SOLE 1,417,212 Decode Genetics COM 2435686104 94 240,667 SH SOLE 240,667 Dendreon COM 24823Q107 482 84,423 SH SOLE 84,423 Depomed COM 249908104 1,961 537,217 SH SOLE 537,217 Genelabs Technologies Inc. COM 368706206 67 154,937 SH SOLE 154,937 Genomic Health Inc. COM 37244C101 117,788 5,200,387 SH SOLE 5,200,387 Halozyme Therapeutics Inc. COM 40637H109 24,804 3,379,264 SH SOLE 3,379,264 Icagen Inc. COM 45104P104 45 46,373 SH SOLE 46,373 Idera Pharmaceuticals Inc. COM 45168K108 8,086 574,684 SH SOLE 574,684 Immunogen Inc. COM 45253H101 2,471 503,334 SH SOLE 503,334 Immunomedics, Inc. COM 452907108 85 47,704 SH SOLE 47,704 Incyte Corp. COM 45337C102 77,398 10,117,432 SH SOLE 10,117,432 Indevus Pharmaceuticals COM 454072109 4,878 1,456,210 SH SOLE 1,456,210 Infinity Pharmaceuticals Inc. COM 45665G303 664 85,632 SH SOLE 85,632 Inhibitex Inc. COM 45719T103 75 203,065 SH SOLE 203,065 Inspire COM 457733103 4,557 1,276,390 SH SOLE 1,276,390 Intermune Inc. COM 45884X103 18,095 1,057,555 SH SOLE 1,057,555 Lev Pharmaceuticals COM 52730C101 1,194 550,421 SH SOLE 550,421 Medarex COM 583916101 2,024 312,834 SH SOLE 312,834 Metabasis Therapeutics Inc. COM 59101M105 2,588 2,290,668 SH SOLE 2,290,668 Micromet COM 59509C105 16,500 3,724,585 SH SOLE 3,724,585 Myriad Genetics Inc. COM 62855J104 21,094 325,121 SH SOLE 325,121 Neose Technologies Inc. COM 640522108 720 2,251,191 SH SOLE 2,251,191 Neurocrine Biosciences COM 64125C109 196 41,861 SH SOLE 41,861 Neurogen Corp. COM 64124E106 1,969 8,205,406 SH SOLE 8,205,406 Novo-Nordisk COM 670100205 21,666 423,167 SH SOLE 423,167 Onyx Inc. COM 683399109 2,590 71,577 SH SOLE 71,577 Optimer Pharmaceuticals COM 68401H104 9,036 1,136,580 SH SOLE 1,136,580 OSI Pharmaceuticals COM 671040103 1,486 30,144 SH SOLE 30,144 Pharmasset Inc. COM 71715N106 1,052 52,747 SH SOLE 52,747 Pozen Inc. COM 73941U102 1,707 162,384 SH SOLE 162,384 Progenics Pharmaceuticals COM 743187106 8,699 653,544 SH SOLE 653,544 Regeneron COM 78556F107 4,354 199,460 SH SOLE 199,460 Rigel Pharmaceuticals COM 766559603 1,218 52,160 SH SOLE 52,160 Salix Pharmaceuticals, Inc. COM 795435106 8,102 1,263,954 SH SOLE 1,263,954 Seattle Genetics Inc. COM 812578102 138,160 12,912,124 SH SOLE 12,912,124 Sequenom Inc. COM 817337405 534 20,053 SH SOLE 20,053 Siga Technologies Inc. COM 826917106 2,364 630,345 SH SOLE 630,345 Spectrum Pharmaceuticals Inc. COM 84763A108 364 257,942 SH SOLE 257,942 Sunesis Pharmaceuticals Inc. COM 867328502 1,222 1,286,466 SH SOLE 1,286,466 Supergen COM 868059106 1,365 961,314 SH SOLE 961,314 Symyx Technologies, Inc. COM 87155S108 2,625 264,882 SH SOLE 264,882 Tapestry Pharmaceuticals Inc. COM 876031204 17 1,939,453 SH SOLE 1,939,453 Targacept COM 87611R306 2,540 437,181 SH SOLE 437,181 Threshold Pharma COM 885807107 1,956 1,504,711 SH SOLE 1,504,711 Torreypines Therapeutics COM 89235K105 96 204,452 SH SOLE 204,452 Trimeris Inc. COM 896263100 13,602 3,461,175 SH SOLE 3,461,175 Vanda Pharmaceuticals Inc. COM 921659108 212 225,142 SH SOLE 225,142 Vertex Pharmaceuticals Inc. COM 92532F100 288 8,665 SH SOLE 8,665 Via Pharmaceuticals COM 92554T103 120 102,881 SH SOLE 102,881 Vion Pharm COM 927624AA4 16 43,101 SH SOLE 43,101 Viropharma Inc. COM 928241108 99,006 7,546,147 SH SOLE 7,546,147 Xenoport Inc. COM 98411C100 36,798 758,883 SH SOLE 758,883 Zymogenetics COM 98985T109 770 115,561 SH SOLE 115,561 Amylin Pharmaceuticals Notes 2.5% 4/15/11 CONV BONDS 032346AD0 21,529 23,465,000 PRN SOLE 23,465,000 Biomarin Pharmaceuticals Notes 1.875% 4/23/2017 CONV BONDS 09061GAD3 17,055 12,000,000 PRN SOLE 12,000,000 Biomarin Pharmaceuticals Notes 2.5% 3/29/2013 CONV BONDS 09061GAC5 31,323 18,224,000 PRN SOLE 18,224,000 Incyte Genomics Notes 3.5% 2/15/2011 CONV BONDS 45337CAE2 17,383 18,972,000 PRN SOLE 18,972,000 Incyte Genomics Notes 3.5% 2/15/2011 CONV BONDS 45337CAF9 17,997 19,750,000 PRN SOLE 19,750,000 Intermune Inc Notes .25% 3/01/2011 CONV BONDS 45884XAC7 16,069 15,000,000 PRN SOLE 15,000,000 Medarex Inc Notes 2.25% 5/15/2011 CONV BONDS 583916AG6 11,135 13,158,000 PRN SOLE 13,158,000 Vertex Pharmaceuticals Notes 4.75% 2/15/13 CONV BONDS 92532FAM2 39,149 25,948,000 PRN SOLE 25,948,000 Viropharma Inc. Notes 2.0% 3/15/2017 CONV BONDS 928241AH1 36,731 45,000,000 PRN SOLE 45,000,000
-----END PRIVACY-ENHANCED MESSAGE-----